Legend Biotech (LEGN) EBIAT (2019 - 2025)
Historic EBIAT for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to -$39.7 million.
- Legend Biotech's EBIAT rose 6833.01% to -$39.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$266.0 million, marking a year-over-year decrease of 3072.13%. This contributed to the annual value of -$177026.0 for FY2024, which is 6584.18% up from last year.
- As of Q3 2025, Legend Biotech's EBIAT stood at -$39.7 million, which was up 6833.01% from -$125.4 million recorded in Q2 2025.
- Legend Biotech's EBIAT's 5-year high stood at $26284.0 during Q4 2024, with a 5-year trough of -$199.1 million in Q2 2023.
- Its 5-year average for EBIAT is -$83.9 million, with a median of -$88.3 million in 2021.
- Per our database at Business Quant, Legend Biotech's EBIAT plummeted by 3557017.6% in 2022 and then surged by 11814.97% in 2024.
- Over the past 5 years, Legend Biotech's EBIAT (Quarter) stood at -$88.3 million in 2021, then plummeted by 53.82% to -$135.9 million in 2022, then surged by 99.89% to -$144818.0 in 2023, then surged by 118.15% to $26284.0 in 2024, then plummeted by 151100.61% to -$39.7 million in 2025.
- Its EBIAT was -$39.7 million in Q3 2025, compared to -$125.4 million in Q2 2025 and -$100.9 million in Q1 2025.